Dance Biopharm Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Dance Biopharm Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C11423
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Dance Biopharm Inc (Dance Biopharm), a subsidiary of Dance Biopharm Holdings Inc, formerly Dance Pharmaceuticals Inc, is a biotechnology company that develops inhaled insulin products to treat diabetes patients. The company provides product pipeline such as Dance-501, a pocket-sized inhaler device and insulin container, among others. It has completed Phase II clinical trials and is in preparation for pivotal development. Dance Biopharm offers Dance-501 that being designed to control prandial blood sugar in adults with diabetes without the need for injections. The company develops liquid formulation of insulin based on the vibrating mesh micropump technology developed and commercialized by Aerogen. Dance Biopharm is headquartered in San Francisco, California, the US.

Dance Biopharm Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Dance Biopharm Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Dance Biopharm Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Dance Biopharm Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Dance Biopharm Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Dance Biopharm Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Dance Biopharm Inc, Medical Equipment, Deal Details 10
Partnerships 10
Dance Biopharm Enters into Co-Development Agreement with Phillips-Medisize 10
Dance Biopharm Forms Joint Venture With Harmony Asset To Develop Inhaled Insulin 11
Hikma Pharma Enters Into Licensing Agreement With Dance Biopharm For Inhaled Insulin Product 12
Equity Offering 13
Dance Biopharm Withdraws IPO for USD75 Million 13
Debt Offering 14
Dance Biopharm Raises USD9.5 Million in Private Placement of Note and Warrants 14
Dance Biopharm Inc – Key Competitors 15
Dance Biopharm Inc – Key Employees 16
Dance Biopharm Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Dance Biopharm Inc, Medical Equipment, Key Facts 2
Dance Biopharm Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Dance Biopharm Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Dance Biopharm Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Dance Biopharm Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Dance Biopharm Inc, Deals By Market, 2012 to YTD 2018 8
Dance Biopharm Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Dance Biopharm Enters into Co-Development Agreement with Phillips-Medisize 10
Dance Biopharm Forms Joint Venture With Harmony Asset To Develop Inhaled Insulin 11
Hikma Pharma Enters Into Licensing Agreement With Dance Biopharm For Inhaled Insulin Product 12
Dance Biopharm Withdraws IPO for USD75 Million 13
Dance Biopharm Raises USD9.5 Million in Private Placement of Note and Warrants 14
Dance Biopharm Inc, Key Competitors 15
Dance Biopharm Inc, Key Employees 16

List of Figures
Dance Biopharm Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Dance Biopharm Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Dance Biopharm Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Dance Biopharm Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Dance Biopharm Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Dance Biopharm Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Dance Biopharm Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Dance Biopharm Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Dance Biopharm Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Coloplast AS (COLO B):企業の財務・戦略的SWOT分析
    Coloplast AS (COLO B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Xtant Medical Holdings Inc (XTNT):製薬・医療:M&Aディール及び事業提携情報
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings Inc, is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowr …
  • Translate Bio Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Translate Bio Inc (Translate Bio), formerly RaNA Therapeutics Inc is a healthcare service provider that develops therapies which targets RNA within cells in the body to selectively activate protein expression. The company provides platform oligonucleotides (oligos) are molecules designed to …
  • Okklo Life Sciences BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Okklo Life Sciences BV (Okklo) is a biopharmaceutical company that develops novel therapeutic solutions. The company offers cyclodextrin-based medicines for the treatment of neglected and orphan diseases. It also develops therapeutics for infectious diseases and lysosomal storage diseases. O …
  • La Francaise Des Jeux SA:企業の戦略的SWOT分析
    La Francaise Des Jeux SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • NuvOx Pharma LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary NuvOx Pharma LLC (NuvOx Pharma) is a biotechnology company that develops oxygen therapeutics for the treatment of human diseases. The company develops novel therapies and formulations based on dodecafluoropentane emulsion platform. Its pipeline products include compounds such as NVX-108, NVX …
  • Tampa Electric Co:企業の戦略的SWOT分析
    Tampa Electric Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Orange Polska S.A.:戦略・SWOT・企業財務分析
    Orange Polska S.A. - Strategy, SWOT and Corporate Finance Report Summary Orange Polska S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Mastek Ltd (MASTEK):企業の財務・戦略的SWOT分析
    Mastek Ltd (MASTEK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Agros Development Company “Proodos” Public Ltd:企業の戦略・SWOT・財務情報
    Agros Development Company “Proodos” Public Ltd - Strategy, SWOT and Corporate Finance Report Summary Agros Development Company “Proodos” Public Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Dah Chong Hong Holdings Ltd (1828):企業の財務・戦略的SWOT分析
    Dah Chong Hong Holdings Ltd (1828) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • OncoSec Medical Inc (ONCS):製薬・医療:M&Aディール及び事業提携情報
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company that offers services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through i …
  • Angelini Group:製薬・医療:M&Aディール及び事業提携情報
    Summary Angelini Group (Angelini) manufactures, markets and distributes pharmaceutical and healthcare products. The company operates in prescription and over-the-counter (OTC) pharmaceutical sectors with focus on pain and inflammation disorders, infection control and infectious diseases and central …
  • Furukawa Electric Co., Ltd.:企業の戦略・SWOT・財務分析
    Furukawa Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Furukawa Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Ethicon US LLC:企業の戦略的SWOT分析
    Ethicon US LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • KKR & Co. Inc:企業の戦略・SWOT・財務分析
    KKR & Co. Inc - Strategy, SWOT and Corporate Finance Report Summary KKR & Co. Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Australian Postal Corporation:企業の戦略・SWOT・財務分析
    Australian Postal Corporation - Strategy, SWOT and Corporate Finance Report Summary Australian Postal Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Monarch Casino & Resort, Inc.:企業の戦略・SWOT・財務情報
    Monarch Casino & Resort, Inc. - Strategy, SWOT and Corporate Finance Report Summary Monarch Casino & Resort, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Harbour Centre Development Ltd:戦略・SWOT・企業財務分析
    Harbour Centre Development Ltd - Strategy, SWOT and Corporate Finance Report Summary Harbour Centre Development Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Abionic SA-医療機器分野:企業M&A・提携分析
    Summary Abionic SA (Abionic) is a medical device company that develops, produces, and markets in vitro diagnostic devices. The company offers products such as abioSCOPE, IVD capsule, abioGUIDE, abioGUIDE application for android, iPhone & iPad, and accessories. Its abioSCOPE in vitro tests are design …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆